The 102nd Meeting of the “Advisory Board on Occupational vs. Non

News Highlights

The 102nd “Advisory Board on Occupational vs. Non-Occupational Ionizing Radiation Disorders” will be held on May 20, 2026. This meeting serves as a forum to discuss the criteria for determining whether health disorders of workers engaged in radiation work are occupational in nature, and the associated compensation system. While specific agenda items and decisions have not yet been publicly announced, it is anticipated that important discussions will take place concerning the assurance of safety in the use of radiation in medical settings and the protection of workers’ rights.

M&A Medical Editorial Department’s Perspective

While the 102nd Advisory Board on Ionizing Radiation Disorders may seem like a topic distant from the daily operations of medical institutions, it actually contains points that cannot be overlooked in medical M&A, particularly in the business succession of clinics and hospitals with strengths in radiation therapy and diagnostic imaging. This is because the “occupational vs. non-occupational” judgment criteria and compensation discussed at the meeting can influence the evaluation of future medical litigation risks and contingent liabilities linked to them. For example, in M&A involving medical institutions that have introduced or previously introduced the latest radiation therapy equipment, it is necessary to closely monitor the discussion trends of this advisory board and meticulously examine potential risks during due diligence (DD). This may serve as a basis for judging the extent to which contingent liabilities should be considered.

Points Highlighted by This News

• The possibility that changes in the criteria for determining occupational vs. non-occupational ionizing radiation disorders may affect the litigation risk assessment of medical institutions
• The importance of evaluating contingent liabilities in M&A of facilities related to radiation therapy and diagnostic imaging
• The possibility that discussions at the advisory board may influence future insurance premium rates and risk management systems for medical institutions
• The possibility that the quality of safety management systems and employee training at medical institutions may indirectly affect the evaluation of M&A

Practical Questions Arising from This News

• What specific criteria changes are likely to be discussed at this advisory board meeting?
• What points should be noted in M&A of medical institutions where radiation-related disorders have occurred in the past?
• Based on the discussions at the advisory board, what kind of safety management systems should medical institutions strengthen?

If You Feel “Should I Consult?”

If your institution possesses or operates radiation therapy or advanced diagnostic imaging equipment, the discussions at this advisory board meeting may impact the evaluation of future litigation risks and contingent liabilities. Especially if you are considering business succession or M&A, it is important to closely monitor the trends of this advisory board and conduct risk assessments with experts. Consulting with experts at an early stage can reduce future management risks and lead to smooth business succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a completely success-fee basis as a business succession support institution certified by the Small and Medium Enterprise Agency. We handle consultations with strict confidentiality. Free consultation here